Dentis receives China NMPA approval for SQ Implant, plans direct sales

Dentis has received NMPA approval for its premium implant product 'SQ Implant' in China, enabling direct sales. The company plans to ship an initial volume worth $2 million starting July 2023 and aims to expand sales to over $8 million within the year.

“We plan to ship an initial volume worth 2 million USD starting this month.”asiae.co.kr

• 1 source
• asiae.co.kr[Featured Stock] Dentis Dreams of Becoming the 'Second Osstem Implant' with Large-Scale Expansion... Approval for Premium Products in China - The Asia Business DailyJul 10, 2023

Summarized from public sources; check the original articles before acting on it.